» Articles » PMID: 3654276

Significant Depletion of NPY in the Innervation of the Rat Mesenteric, Renal Arteries and Kidneys in Experimentally (aorta Coarctation) Induced Hypertension

Overview
Journal Histochemistry
Specialty Biochemistry
Date 1987 Jan 1
PMID 3654276
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The distribution and concentrations of neuropeptide Y (NPY) in kidneys, renal arteries, heart, aorta, mesenteric artery and adrenal glands from aorta-ligated hypertensive rats were studied by immunocytochemistry and radioimmunoassay. Immunocytochemistry showed that in the hypertensive animals NPY-immunoreactive fibres were decreased in both kidney and renal artery, above and below the ligation, and in mesenteric arteries. The depletion of NPY-containing nerves in the kidney was more pronounced around the juxtaglomerular apparatus than in other areas of the organ. By radioimmunoassay, the concentrations of NPY immunoreactivity were significantly lower in the hypertensive animals when compared with the controls, (kidney: hypertensive 1.0 +/- 0.1; controls 2.0 +/- 0.2 pmol/g, mean +/- SEM; p less than 0.05 renal artery: hypertensive 5.0 +/- 0.8; controls 12.1 +/- 2.0; p less than 0.05 and mesenteric artery: hypertensive 8.6 +/- 1.9; 17.6 +/- 3.0; p less than 0.01). While there were no statistically significant changes in the levels of NPY immunoreactivity in the other areas studied, there was a general trend for the level to fall in the renal artery below the ligation (hypertensive 10.6 +/- 1.5; control 15.3 +/- 2.4; p greater than 0.05). It is of interest that changes were observed in the vasoconstrictor peptide NPY in this commonly used model of hypertension.

Citing Articles

Differential effect of neuropeptide-Y on membrane potential of cells in renal arterioles of the hydronephrotic mouse.

Nobiling R, Gabel M, Persson P, Dietrich M, Buhrle C J Physiol. 1991; 444:317-27.

PMID: 1822553 PMC: 1179935. DOI: 10.1113/jphysiol.1991.sp018880.


Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs.

Persson P, Ehmke H, Nafz B, Lang R, HACKENTHAL E, Nobiling R J Physiol. 1991; 444:289-302.

PMID: 1688030 PMC: 1179933. DOI: 10.1113/jphysiol.1991.sp018878.

References
1.
Carretero O, Kuk P, Piwonska S, Houle J . Role of the renin-angiotensin system in the pathogenesis of severe hypertension in rats. Circ Res. 1971; 29(6):654-63. DOI: 10.1161/01.res.29.6.654. View

2.
Lundberg J, Tatemoto K . Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand. 1982; 116(4):393-402. DOI: 10.1111/j.1748-1716.1982.tb07157.x. View

3.
Lundberg J, Terenius L, Hokfelt T, Martling C, Tatemoto K, Mutt V . Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982; 116(4):477-80. DOI: 10.1111/j.1748-1716.1982.tb07171.x. View

4.
Tatemoto K, Carlquist M, Mutt V . Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982; 296(5858):659-60. DOI: 10.1038/296659a0. View

5.
Ballesta J, Polak J, Allen J, Bloom S . The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY. Histochemistry. 1984; 80(5):483-5. DOI: 10.1007/BF00495438. View